Ho D, Tsui Y, Chan L, Sze K, Zhang X, Cheu J, et al. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma. Nat Commun. 2021;12:3684 pubmed publisher

Ivasko S, Anders K, Grunewald L, Launspach M, Klaus A, Schwiebert S, et al. Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model. Front Immunol. 2022;13:1023206 pubmed publisher

Cribioli E, Giordano Attianese G, Ginefra P, Signorino Gelo A, Vuillefroy de Silly R, Vannini N, et al. Enforcing GLUT3 expression in CD8+ T cells improves fitness and tumor control by promoting glucose uptake and energy storage. Front Immunol. 2022;13:976628 pubmed publisher

Hu J, Yang Q, Zhang W, Du H, Chen Y, Zhao Q, et al. Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors. J Immunother Cancer. 2022;10: pubmed publisher

He X, Zhou S, Dolan M, Shi Y, Wang J, Quinn B, et al. Immunization with short peptide particles reveals a functional CD8+ T-cell neoepitope in a murine renal carcinoma model. J Immunother Cancer. 2021;9: pubmed publisher

He X, Zhou S, Quinn B, Huang W, Jahagirdar D, Vega M, et al. Position-Scanning Peptide Libraries as Particle Immunogens for Improving CD8+ T-Cell Responses. Adv Sci (Weinh). 2021;8:e2103023 pubmed publisher

Henkle T, Lam B, Kung Y, Lin J, Tseng S, Ferrall L, et al. Development of a novel mouse model of spontaneous high-risk HPVE6/E7-expressing carcinoma in the cervicovaginal tract. Cancer Res. 2021;: pubmed publisher

Sun M, Gu P, Yang Y, Yu L, Jiang Z, Li J, et al. Mesoporous silica nanoparticles inflame tumors to overcome anti-PD-1 resistance through TLR4-NFκB axis. J Immunother Cancer. 2021;9: pubmed publisher

Wu M, Xia X, Hu J, Fowlkes N, Li S. WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression. Nat Commun. 2021;12:3500 pubmed publisher

Truckenbrod E, Burrack K, Knutson T, Borges da Silva H, Block K, O Flanagan S, et al. CD8+ T cell self-tolerance permits responsiveness but limits tissue damage. elife. 2021;10: pubmed publisher

Habener A, Happle C, Grychtol R, Skuljec J, Busse M, Dal xfc ge K, et al. Regulatory B cells control airway hyperreactivity and lung remodeling in a murine asthma model. J Allergy Clin Immunol. 2021;147:2281-2294.e7 pubmed publisher

Molgora M, Esaulova E, Vermi W, Hou J, Chen Y, Luo J, et al. TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy. Cell. 2020;182:886-900.e17 pubmed publisher

Pein M, Insua Rodríguez J, Hongu T, Riedel A, Meier J, Wiedmann L, et al. Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs. Nat Commun. 2020;11:1494 pubmed publisher

Krummey S, Morris A, Jacobs J, McGuire D, Ando S, Tong K, et al. CD45RB Status of CD8+ T Cell Memory Defines T Cell Receptor Affinity and Persistence. Cell Rep. 2020;30:1282-1291.e5 pubmed publisher